SCHEMBL19294163

SCHEMBL19294163

CCC(=O)Oc1cc(C(F)(F)F)ccc1C(=O)O

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.71
ALDH1A1 P00352 3/20 0.71
HPGD P15428 3/20 0.71
HSD17B10 Q99714 2/20 0.71
CYP2C19 P33261 2/20 0.71
USP2 O75604 1/20 0.71
MRGPRX4 Q96LA9 5/20 0.44
CFTR P13569 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CYP1A2 P05177 2/20 0.42
ALOX12 P18054 1/20 0.42
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
CES2 O00748 1/20 0.41
ACHE P22303 1/20 0.41
RECQL P46063 1/20 0.41
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
SORT1 Q99523 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25527364 0.85 ALDH1A1 (0.67) KDM4EALDH1A1HPGDHSD17B10CYP2C19
SCHEMBL1996213 0.85 ALDH1A1 (0.50) KDM4EALDH1A1HPGDHSD17B10CYP2C19
SCHEMBL5940761 0.84 KDM4E (0.61) KDM4EALDH1A1HPGDHSD17B10CYP2C19
Triflusal SCHEMBL29435450 0.83 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10CYP2C19
Triflusal SCHEMBL29435449 0.83 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10CYP2C19
Triflusal SCHEMBL136423 0.83 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10CYP2C19
SCHEMBL5943428 0.82 KDM4E (0.59) KDM4EALDH1A1HPGDHSD17B10CYP2C19
SCHEMBL954464 0.82 HSD17B10 (0.66) KDM4EALDH1A1HPGDHSD17B10CYP2C19
Triflusal SCHEMBL4960641 0.82 KDM4E (0.97) KDM4EALDH1A1HPGDHSD17B10CYP2C19
SCHEMBL4307017 0.81 KDM4E (0.78) KDM4EALDH1A1HPGDHSD17B10CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170246193-A1 FATTY ACID ACETYLATED SALICYLATES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2017-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170246193-A1 FATTY ACID ACETYLATED SALICYLATES AND THEIR USES FASN, ACACA, FABP4 KDM4E 2493/4885ALDH1A1 285/4885HPGD 510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.